PSNPrescribable
upadacitinib 15 MG 24HR Extended Release Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Rinvoq Tablet, Extended Release
RxNorm Crosswalk NDC 0074-1043
View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC
RxNorm Mapping Clinical Concepts
This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
The product Rinvoq (NDC 0074-1043) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 8 unique RxNorm concepts. By anchoring Abbvie Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
SCDPrescribable
Featured Concept
24 HR upadacitinib 15 MG Extended Release Oral Tablet
(RxCUI 2196894)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
RINVOQ 15 MG 24HR Extended Release Oral Tablet
(RxCUI 2196900)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
24 HR upadacitinib 30 MG Extended Release Oral Tablet
(RxCUI 2590051)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
RINVOQ 30 MG 24HR Extended Release Oral Tablet
(RxCUI 2590054)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
24 HR upadacitinib 45 MG Extended Release Oral Tablet
(RxCUI 2596957)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
RINVOQ 45 MG 24HR Extended Release Oral Tablet
(RxCUI 2596960)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
upadacitinib 1 MG/ML Oral Solution
(RxCUI 2681015)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
RINVOQ LQ 1 MG in 1 mL Oral Solution
(RxCUI 2681019)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
Understanding RxNorm Mapping for Rinvoq
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 0074-1043 to RxCUI 2196894, 2196900, 2590051, 2590054, 2596957, 2596960, 2681015, 2681019, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
- PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
- SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
- SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
- SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
* Please review the full disclaimer at the bottom of this page.
